Dolby Laboratories (NYSE:DLB) Stock Gets Price Target Trim from Robert W. Baird

Dolby Laboratories (NYSE:DLB – Free Report) had its price target lowered by Robert W. Baird from $62.00 to $60.00 in a report released on Thursday,Benzinga reports. The brokerage currently has a neutral rating on the electronics maker’s stock.

Several other equities research analysts also recently issued reports on DLB. Rosenblatt Securities cut their target price on shares of Dolby Laboratories from $85.00 to $80.00 and set a “buy” rating for the company in a research note on Monday, November 16th. Zacks Research upgraded Dolby Laboratories from a “strong sell” rating to a “hold” rating in a report on Friday, November 13th. Weiss Ratings raised Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, September 9th. Finally, Wall Street Zen downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Two research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $76.67.

View Our Latest Stock Analysis on Dolby Laboratories

Dolby Laboratories Trading Up 0.8%

Shares of DLB opened at $55.22 on Thursday. The company has a market cap of $5.17 billion, a price-to-earnings ratio of 20.45 and a beta of 0.79. Dolby Laboratories has a 1-year low of $48.26 and a 1-year high of $69.95. The company’s fifty day simple moving average is $60.46 and its 200 day simple moving average is $59.29.

Dolby Laboratories (NYSE:DLB – Get Free Report) last announced its quarterly earnings results on Tuesday, November 17th. The electronics maker reported $1.25 EPS for the quarter, beating analysts’ consensus estimates of $1.20 by $0.05. The firm had revenue of $373.54 million during the quarter, compared to analysts’ expectations of $372.76 million. Dolby Laboratories had a net margin of 18.14% and a return on equity of 11.77%. The company’s revenue for the quarter was up 21.7% compared to the same quarter last year. During the same quarter last year, the company posted $0.99 earnings per share. Dolby Laboratories has set its Q1 2027 guidance at 0.410-0.560 EPS and its FY 2027 guidance at 4.270-4.420 EPS. As a group, research analysts forecast that Dolby Laboratories will post 3.36 earnings per share for the current year.

Dolby Laboratories Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 9th. Shareholders of record on Tuesday, December 1st will be issued a $0.39 dividend. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.36. This represents a $1.56 annualized dividend and a dividend yield of 2.8%. The ex-dividend date is Tuesday, December 1st. Dolby Laboratories’s dividend payout ratio is presently 53.33%.

Dolby Laboratories declared that its Board of Directors has authorized a stock buyback plan on Thursday, July 30th that authorizes the company to buy back $350 million in shares. This repurchase authorization authorizes the electronics maker to repurchase up to 7% of its shares through open market purchases. Share repurchase plans are usually a sign that the company’s management believes its shares are undervalued.

Insider Activity

In related news, CAO Ryan Nicholson sold 1,183 shares of Dolby Laboratories stock in a transaction dated Tuesday, August 25th. The shares were sold at an average price of $65.28, for a total transaction of $77,226.24. Following the completion of the sale, the chief accounting officer owned 34,453 shares of the company’s stock, valued at approximately $2,249,091.84. The trade was a 3.32% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP John D. Couling sold 7,667 shares of the firm’s stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $58.78, for a total transaction of $450,666.26. Following the sale, the senior vice president owned 166,803 shares of the company’s stock, valued at $9,804,680.34. This trade represents a 4.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 16,517 shares of company stock worth $995,963 over the last three months. Insiders own 37.93% of the company’s stock.

Hedge Funds Weigh In On Dolby Laboratories

Institutional investors and hedge funds have recently made changes to their positions in the company. American Century Companies Inc. increased its position in Dolby Laboratories by 38.8% during the 3rd quarter. American Century Companies Inc. now owns 36,760 shares of the electronics maker’s stock worth $2,160,000 after buying an additional 10,273 shares during the period. Advisors Asset Management Inc. acquired a new stake in shares of Dolby Laboratories during the third quarter worth $4,092,000. Algert Global LLC bought a new stake in shares of Dolby Laboratories in the third quarter valued at about $1,666,000. Greenwich Wealth Management LLC bought a new stake in shares of Dolby Laboratories in the third quarter valued at about $217,000. Finally, Lighthouse Investment Partners LLC acquired a new position in shares of Dolby Laboratories in the third quarter valued at about $407,000. Institutional investors and hedge funds own 58.56% of the company’s stock.

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc. develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video. The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.

Recommended Stories

Analyst Recommendations for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.